In endogenous NONO knockdown, total cholesterol and SREBP1/2 expression were investigated in KELLY and patient‐derived high‐risk neuroblastoma cell lines, alongside overexpression experiments using NONO wild‐type and NONO mutants lacking RNA binding capability (ΔRRM1). The gene discussed is SREBF1; the disease is neuroblastoma.